University of Maryland Announces Finalists for $75K Business Plan C...(FDA approval thereby increasing the retu...)

Team: Varnika Roy, graduate research assistant, molecular and cell biology; Dean Berlin, graduate research assistant, Fischell Department of Bioengineering; Amin Zargar, operations manager, McMaster-Carr; William Bentley, Robert E. Fischell Distinguished Professor and Chair, Fischell Department of Bioengineering.

• Haemechanics: has developed the first and only synthetic hemostatic material capable of simultaneously inducing blood clotting and delivering therapeutics. The material is able to induce clotting as effectively as biologically based products, at a fraction of the price.

Team: Brendan Casey, graduate research assistant, Fischell Department of Bioengineering; Adam Behrens, undergraduate research assistant, Fischell Department of Bioengineering; Peter Kofinas, Keystone Professor, Fischell Department of Bioengineering; Bartley Griffith; professor of surgery, chief, division of cardiac surgery, director, heart and lung transplantation, University of Maryland Medical Center.

• XyloFuel LLC: is a newly formed company that aims to license out patented processes for converting plant fiber to fuel ethanol and other products. University of Maryland researchers discovered a bacterium that can readily digest and ferment various forms of plant fiber to ethanol.

Team: Richard Kohn, professor of animal science; Robert Frank, engineering manager, XyloFuel.

Finalists in the undergraduate category include:

• Inari: provides print advertisers with the ability to push information to the mobile devices of interested consumers, while protecting those consumers from unwanted spam. Inari will sell its services based
  '/>"/>